NCT02964429View on ClinicalTrials.gov

Determination In-vivo KUF for Diacap Pro Hemodialyser

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

December 23, 2016

Study Completion Date

December 23, 2016

Conditions

Kidney Failure,ChronicRenal Insufficiency,ChronicKidney Disease, End-StageKidney Insufficiency

Interventions

DEVICE

Diacap Pro High-Flux

During dialysis treatment ultrafiltration rate will be changed following a fixed schedule and resulting changes in Transmembrane Pressure (TMP) recorded to generate data for calculation of the in-vivo KUF.

Trial Locations (1)

169 00 Praha 6

Interní oddělení Strahov VFN, Prague

All Listed Sponsors

collaborator

Winicker Norimed GmbH

INDUSTRY

lead

B.Braun Avitum AG

INDUSTRY

NCT02964429 - Determination In-vivo KUF for Diacap Pro Hemodialyser | Biotech Hunter | Biotech Hunter